Drug intelligence / Profile preview

Breakheal

Development stage: Unknown
Lead developer: Healthon Life Sciences
Modality: Small Molecules
Administration: Oral

Overview

Breakheal is a herbal nutraceutical formulation developed and marketed by Healthon Lifesciences, primarily indicated for bone health and the support of musculoskeletal recovery. It is a combination product available in tablet form, containing extracts of *Cissus quadrangularis* (750mg), *Moringa oleifera* (100mg), and *Withania somnifera* (100mg). *Cissus quadrangularis* is widely used in traditional medicine for its purported ability to accelerate bone fracture healing and increase bone mineral density. *Moringa oleifera* serves as a source of essential nutrients and minerals, while *Withania somnifera* (Ashwagandha) provides adaptogenic and anti-inflammatory benefits. The product is commercially available in India through various retail pharmacy chains.

Brand names: Breakheal

Beyond the preview

Go deeper on Breakheal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Breakheal.

Explore the full profile